Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Viva Biotech
Viva Biotech is a drug discovery platform focused on preclinical-stage drug development.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Venture capital firm
Investor
Company
B2X
B2B
CEO
Cheney Mao
0
Legal Name
Viva Biotech (Shanghai) Ltd.
Company Operating Status
Active
Country
China
0
Crunchbase URL
crunchbase.com/organiz...-biotech
Date Incorporated
2008
Facebook URL
@Viva-Biotech-Ltd-263580669654
Founded Date
2014
0
Founder
Cheney Mao
0
Fengmao Hua
Full Address
No.735, Ziping Road, Pudong New Area, Shanghai 201318, China
0
Headquarters
Shanghai
0
Industry
Biotechnology
Healthcare
Biology
Technology
Biomedical engineering
Engineering
Drug development
Pharmaceutical industry
Invested in
QurAlis
Viva Biotech
Totient
AmacaThera
Totient
Triumvira Immunologics
Investors
Viva Biotech
JMCR Partners
Latest Funding Round Date
July 13, 2018
Latest Funding Round Amount (USD)
7,500,000
Latest Funding Type
Series B Round
Legal classification
Limited liability company
LinkedIn URL
@company/viva-bioinnovator
Location
Shanghai
0
China
Number of Employees (Ranges)
11 – 50
0
Patents Assigned (Count)
3
Phone Number
+862160893288
0
Pitchbook URL
pitchbook.com/profiles...231940-63
Subsidiary
Viva BioInnovator
Total Funding Amount (USD)
37,500,000
Twitter URL
@viva_innovates
Official Website
vivabiotech.com
vivabiotech.com.cn
vivabiotech.com/en/index.php
Wikidata ID
Q30260824
Find more companies like Viva Biotech
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE